Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.
| Image |  |
|---|---|
| Description | scientific article published on 16 October 2017 |
| Author/s |
author: Elaine Jaffe Seth M Steinberg Wyndham H. Wilson Joseph Roswarski Stefania Pittaluga Christopher Melani Thomas Waldmann Mark Roschewski |
| Publication date | October 16, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |